|Related Categories||Approved Therapeutics/Drug Candidates, Cell Biology, Cell Signaling and Neuroscience, Cytoskeleton and Extracellular Matrix, Extracellular Matrix,|
|optical activity||[α]/D ≥15°, c = 0.5 in methanol|
|color||white to off-white|
|solubility||DMSO: >30 mg/mL|
|storage temp.||room temp|
Sold for research purposes under agreement from Pfizer Inc.
UK-383,367 is a procollagen C-proteinase (PCP) inhibitor.
Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: Design, synthesis, and evaluation as topically applied, dermal anti-scarring agents. Bailey, S., et al. Bioorg. Med. Chem. Oct.11th ed.,, (2008)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Need larger quantities for your development, manufacturing or research applications?